Midland Pharmaceuticals launches to advance spinal injury therapeutics

Midland Pharmaceuticals has launched to focus on the development of a therapeutic for spinal cord injury and cerebrovascular disease.

Jun 2, 2024 - 04:00

Midland Pharmaceuticals launches to advance spinal injury therapeutics

Midland Pharmaceuticals has launched to focus on the development of a therapeutic for spinal cord injury and cerebrovascular disease.

Read the original article

Tags:

Previous Article

Swiss biotech ecosystem recuperates from global financial instability

Following a $34 million transaction, ADHD game creator Akili Interactive will go...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: New research may give geneticists a long-sought tool: a targeted protein delivery device

STAT+: New research may give geneticists a long-sought ...

Mar 30, 2023

ChatGPT in medicine: STAT answers readers’ burning questions about AI

ChatGPT in medicine: STAT answers readers’ burning ques...

May 23, 2023

STAT+: FDA cracks down on websites that claim to sell chemicals in obesity drugs Wegovy, Zepbound

STAT+: FDA cracks down on websites that claim to sell c...

Feb 15, 2024